413 related articles for article (PubMed ID: 9016350)
41. Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
Selley DE; Stark S; Sim LJ; Childers SR
Life Sci; 1996; 59(8):659-68. PubMed ID: 8761016
[TBL] [Abstract][Full Text] [Related]
42. Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5'-O-(gamma-thio)-triphosphate binding in rat brain membranes.
Albrecht E; Samovilova NN; Oswald S; Baeger I; Berger H
J Pharmacol Exp Ther; 1998 Aug; 286(2):896-902. PubMed ID: 9694948
[TBL] [Abstract][Full Text] [Related]
43. Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G.
Wang YJ; Huang P; Blendy JA; Liu-Chen LY
Addict Biol; 2014 May; 19(3):354-61. PubMed ID: 22862850
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.
Griffin G; Atkinson PJ; Showalter VM; Martin BR; Abood ME
J Pharmacol Exp Ther; 1998 May; 285(2):553-60. PubMed ID: 9580597
[TBL] [Abstract][Full Text] [Related]
45. Chronic antidepressant treatment causes a selective reduction of mu-opioid receptor binding and functional coupling to G Proteins in the amygdala of fawn-hooded rats.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2004 Sep; 310(3):1020-6. PubMed ID: 15121763
[TBL] [Abstract][Full Text] [Related]
46. Effect of chronic ethanol and withdrawal on the mu-opioid receptor- and 5-Hydroxytryptamine(1A) receptor-stimulated binding of [(35)S]Guanosine-5'-O-(3-thio)triphosphate in the fawn-hooded rat brain: A quantitative autoradiography study.
Chen F; Lawrence AJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):159-65. PubMed ID: 10734165
[TBL] [Abstract][Full Text] [Related]
47. Estrogen modulation of mu-opioid receptor-stimulated [35S]-GTP-gamma-S binding in female rat brain visualized by in vitro autoradiography.
Acosta-Martinez M; Etgen AM
Neuroendocrinology; 2002 Oct; 76(4):235-42. PubMed ID: 12411740
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration.
Maher CE; Martin TJ; Childers SR
Life Sci; 2005 Jul; 77(10):1140-54. PubMed ID: 15890372
[TBL] [Abstract][Full Text] [Related]
49. Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy.
Emmerson PJ; Clark MJ; Medzihradsky F; Remmers AE
J Neurochem; 1999 Jul; 73(1):289-300. PubMed ID: 10386982
[TBL] [Abstract][Full Text] [Related]
50. CB1 receptor-independent actions of SR141716 on G-protein signaling: coapplication with the mu-opioid agonist Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol unmasks novel, pertussis toxin-insensitive opioid signaling in mu-opioid receptor-Chinese hamster ovary cells.
Cinar R; Szücs M
J Pharmacol Exp Ther; 2009 Aug; 330(2):567-74. PubMed ID: 19448142
[TBL] [Abstract][Full Text] [Related]
51. Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.
Mizoguchi H; Wu HE; Narita M; Sora I; Hall SF; Uhl GR; Loh HH; Nagase H; Tseng LF
J Pharmacol Sci; 2003 Dec; 93(4):423-9. PubMed ID: 14737012
[TBL] [Abstract][Full Text] [Related]
52. Effects of neonatal cocaine treatment and gender on opioid agonist-stimulated [(35)S]GTP gamma S binding in the striatum and nucleus accumbens.
Meyer JS; Shani I; Rice D
Brain Res Bull; 2000 Sep; 53(2):147-52. PubMed ID: 11044590
[TBL] [Abstract][Full Text] [Related]
53. Noribogaine stimulates naloxone-sensitive [35S]GTPgammaS binding.
Pablo JP; Mash DC
Neuroreport; 1998 Jan; 9(1):109-14. PubMed ID: 9592058
[TBL] [Abstract][Full Text] [Related]
54. [Effects of newly isolated opioid peptides on G-protein activation: usefulness of [35S] GTP gamma S binding study and its practical application].
Narita M
Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Aug; 18(4):107-16. PubMed ID: 9866825
[TBL] [Abstract][Full Text] [Related]
55. A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence.
Xu H; Partilla JS; Wang X; Rutherford JM; Tidgewell K; Prisinzano TE; Bohn LM; Rothman RB
Synapse; 2007 Mar; 61(3):166-75. PubMed ID: 17152090
[TBL] [Abstract][Full Text] [Related]
56. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
57. SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors.
Xu H; Lu YF; Rice KC; Ananthan S; Rothman RB
Brain Res Bull; 2001 Jul; 55(4):507-11. PubMed ID: 11543951
[TBL] [Abstract][Full Text] [Related]
58. Parallel stimulations of in vitro and in situ [35S]GTPgammaS binding by endomorphin 1 and DAMGO in mouse brains.
Kakizawa K; Shimohira I; Sakurada S; Fujimura T; Murayama K; Ueda H
Peptides; 1998; 19(4):755-8. PubMed ID: 9622032
[TBL] [Abstract][Full Text] [Related]
59. Chronic in utero morphine exposure alters mu-agonist-stimulated [35S]-GTPgammaS binding in neonatal and juvenile guinea pig brainstem regions associated with breathing control.
Matsuda AY; Olsen GD
Neurotoxicol Teratol; 2001; 23(5):413-9. PubMed ID: 11711243
[TBL] [Abstract][Full Text] [Related]
60. Agonist stimulation at human μ opioid receptors in a [(35)S]GTPγS incorporation assay: observation of "bell-shaped" concentration-response relationships under conditions of strong receptor G protein coupling.
Heusler P; Tardif S; Cussac D
J Recept Signal Transduct Res; 2016; 36(2):158-66. PubMed ID: 26466637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
